November 1, 2024

The Pathology of Stargardt Disease and Future Treatment Horizons

By Joseph C. Giacalone, MD, PhD, Brittni A. Scruggs, MD, PhD

October 1, 2024

Clinical Trial Download: The Potential of Optogenetic Therapy

By Yasha Modi, MD , Allen C. Ho, MD, Sulagna Bhattacharya, MBA

September 1, 2024

Upfront: How Far We've Come

By Peter K. Kaiser, MD

September 1, 2024

Current Trials in Uveal Melanoma

By Yehonatan Weinberger, MD, Arun D. Singh, MD

September 1, 2024

New Drug Therapies for Benign Retinal Tumors

By Mary E. Aronow, MD

June 24, 2024

Macular Telangiectasia: New Hope on the Horizon

By Thomas A. Albini, MD, Michael A. Singer, MD

April 1, 2024

Clinical Trial Update April 2024

July 1, 2023

SUBSPECIALTY NEWS: Mydriasis spray approved, laser and imaging devices cleared, new AI technology, and more.

By Rochelle Nataloni, contributing writer

July 1, 2023

Clinical Trial Update July/August 2023

May 1, 2023

An Update on Stem Cell Therapy for Retinal Diseases

By Samuel R. Feldman, MD, Glenn C. Yiu, MD, PhD, Susanna S. Park, MD, PhD

April 1, 2023

Clinical Trial Update April 2023

February 1, 2023

Clinical Trial Update: Special Edition 2023

July 1, 2022

SUBSPECIALTY NEWS: RetinAI gets FDA clearance, suprachoroidal therapy update, GA trial data, and more.

By Rochelle Nataloni, contributing writer